Health risk of chrysotile revisited

Critical Reviews in Toxicology

Volumn 43, Issue 2, 2013, Pages 154-183

  Bernstein, David ^a   Dunnigan, Jacques ^b   Hesterberg, Thomas ^c   Brown, Robert ^d   Velasco, Juan Antonio Legaspi ^e   Barrera, Raúl ^f   Hoskins, John ^g   Gibbs, Allen ^h  

^a Consultant in Toxicology ^*  (Switzerland)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c Center for Toxicology and Environmental Health   (United States)

^d Toxicology Services   (United Kingdom)

^e Academia Nacional de Medicina   (Mexico)

^f INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^g Independent Toxicologist   (United Kingdom)

^h LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Amphibole asbestos; Cement products; Chrysotile; Epidemiology; Health risk; Inhalation toxicology; Mining

Indexed keywords

AMOSITE; AMPHIBOLE; ASBESTOS; CARBON NANOTUBE; CHRYSOTILE; CROCIDOLITE; MAGNESIUM; MAGNESIUM HYDROXIDE; SERPENTINE; TREMOLITE;

ADVERSE OUTCOME; AEROSOL; CANCER RISK; CARCINOGENICITY; CELL PROLIFERATION; CHRONIC TOXICITY; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FIBROSING ALVEOLITIS; HUMAN; IN VITRO STUDY; LUNG CANCER; MACROPHAGE; MESOTHELIOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; PATHOGENICITY; PLEURA CAVITY; PLEURISY; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ASBESTOS, AMPHIBOLE; ASBESTOS, SERPENTINE; ASBESTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHALATION EXPOSURE; LUNG; LUNG NEOPLASMS; MACROPHAGES; PARTICLE SIZE; PLEURAL NEOPLASMS;

EID: 84872955143     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2012.756454     Document Type: Review

References (193)

1. Adamson IY, Bakowska J, Bowden DH. (1993). Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung. Am J Pathol, 142, 1209-16.
2. Adamson IY, Bakowska J, Bowden DH. (1994). Mesothelial cell proliferation: a nonspecific response to lung injury associated with fibrosis. Am J Respir Cell Mol Biol, 10, 253-8.
3. Addison J, Davies LS. (1990). Analysis of amphibole asbestos in chrysotile and other materials. Ann Occup Hyg, 34, 159-75.
4. Aguilar-Madrid G, Robles-Pérez E, Juárez-Pérez CA, et al. (2010). Casecontrol study of pleural mesothelioma in workers with social security in Mexico. Am J Ind Med, 53, 241-51.
5. Ashcroft T. (1973). Epidemiological and quantitative relationships between mesothelioma and asbestos on Tyneside. J Clin Pathol, 26, 832-40.
6. Aust AE, Cook PM, Dodson RF. (2011). Morphological and chemical mechanisms of elongated mineral particle toxicities. J Toxicol Environ Health B Crit Rev, 14, 40-75.
7. Ballweg JA, Bray RM. (1989). Smoking and tobacco use by US military personnel. Mil Med, 154, 165-8.
8. Balzer JL, Cooper WC. (1968). The work environment of insulating workers. Am Ind Hyg Assoc J, 29, 222-7.
9. Barbieri PG, Mirabelli D, Somigliana A, et al. (2012). Asbestos fibre burden in the lungs of patients with mesothelioma who lived near asbestos-cement factories. Ann Occup Hyg. 2012. [Epub ahead of print]. doi:10.1093/annhyg/ mer126.
10. Bates TF, Sand LB, Mink JF. (1950). Tubular crystals of chrysotile asbestos. Science, 111, 512-3.
11. Bellmann B, Muhle H, Creutzenberg O, et al. (2003). Calibration study on subchronic inhalation toxicity of man-made vitreous fibers in rats. Inhal Toxicol, 15, 1147-77.
12. Berman DW, Crump KS. (2003). Draft technical support document for a protocol to assess asbestos-related risk [report]. Washington (DC): Office of Solid Waste and Emergency Response US Environmental Protection Agency.
13. Berman DW, Crump KS. (2008). A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol, 38, 49-73.
14. Berman DW, Crump KS, Chatfield EJ, et al. (1995). The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF/HAN rats following inhalation. Risk Anal, 15, 181-95.
15. Bernstein DM. (2007). Synthetic vitreous fibers: a review toxicology, epidemiology and regulations. Crit Rev Toxicol, 37, 839-86.
16. Bernstein D, Castranova V, Donaldson K, et al. (2005c). Testing of fibrous particles: short-term assays and strategies. Inhal Toxicol, 17, 497-537.
17. Bernstein DM, Chevalier J, Smith P. (2005b). Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology following short term exposure. Inhal Toxicol, 17, 427-49.
18. Bernstein DM, Riego-Sintes JM, Ersboell BK, et al. (2001a). Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal Toxicol, 13, 823-49.
19. Bernstein DM, Riego-Sintes JM, Ersboell BK, et al. (2001b). Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumour response in rats. Inhal Toxicol, 13, 851-75.
20. Bernstein DM, Rogers R, Chevalier J, et al. (2006). The toxicological response of Brazilian chrysotile asbestos: a multidose sub-chronic 90 d inhalation toxicology study with 92 day recovery to assess cellular and pathological response. Inhal Toxicol, 18, 313-32.
21. Bernstein DM, Rogers RA, Sepulveda R, et al. (2010). The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short term inhalation exposure-interim results. Inhal Toxicol, 22, 937-62.
22. Bernstein DM, Rogers RA, Sepulveda R, et al. (2011). Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol, 23, 372-91.
23. Bernstein DM, Rogers R, Smith P. (2003). The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol, 15, 101-28.
24. Bernstein DM, Rogers R, Smith P. (2004). The biopersistence of Brazilian chrysotile asbestos following inhalation. Inhal Toxicol, 16, 745-61.
25. Bernstein DM, Rogers R, Smith P. (2005a). The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol, 17, 1-14.
26. Berry G, Newhouse ML. (1983). Mortality of workers manufacturing friction materials using asbestos. Br J Ind Med, 40, 1-7.
27. Bolton RE, Vincent JH, Jones AD, et al. (1983). An overload hypothesis for pulmonary clearance of UICC amosite fibres inhaled by rats. Br J Ind Med, 40, 264-72.
28. Bowles O, Barsigian FM. (1954). Asbestos, In: McGann PW, ed. Minerals yearbook 1951, Bureau of Mines. United States Government Printing Office, 167-76. Available from: http://digital.library.wisc. edu/1711.dl/EcoNatRes. MinYB1951.
29. Bowles O, Stoddard BH. (1933). Asbestos, In: Kiessling OE, ed. Minerals yearbook 1932-33, United States Government Printing Office, 1933, 745-52. Available from: http://digital.library.wisc.edu/1711.dl/EcoNatRes.MinYB193132.
30. Bragg GM. (2001). Fiber release during the handling of products containing chrysotile asbestos using modern control technology. In: Nolan RP, Langer AM, Ross M, et al., eds. The health effects of chrysotile asbestos: contribution of science to risk-management decisions. Ottawa, Canada: Canadian Mineralist, Spec. Publ. 5, 111-14.
31. Bray RM, Guess LL, Marsden ME. (1989). Prevalence, trends, and correlates of alcohol use, nonmedical drug use, and tobacco use among US military personnel. Mil Med, 154, 1-11.
32. Bray RM, Marsden ME, Peterson MR. (1991). Standardized comparisons of the use of alcohol, drugs, and cigarettes among military personnel and civilians. Am J Public Health, 81, 865-9.
33. Breysse PN, Cherrie JW, Addison J, et al. (1989). Evaluation of airborne asbestos concentrations using TEM and SEM during residential water tank removal. Ann. Occup Hyg, 33, 243-56.
34. Campbell WJ, Huggins CW, Wylie AG. (1980). Chemical and physical characterization of amosite, chrysotile, crocidolite, and nonfibrous tremolite for oral ingestion studies by the national institute of environmental health sciences [report of investigation 8452]. Avondale (MD): United States Department of The Interior, US Bureau of Mines.
35. Carel R, Olsson AC, Zaridze D, et al. (2007). Occupational exposure to asbestos and man-made vitreous fibers and risk of lung cancer: a multicentre case-control study in Europe. Occup Environ Med, 64, 502-8.
36. Case BW, Abraham JL. (2009). Heterogeneity of exposure and attribution of mesothelioma: trends and strategies in two American counties. J Phys: Conf Ser, 151, 012008.
37. Case BW, Dufresne A, McDonald AD, et al. (2000). Asbestos fibre type and length in lungs of chrysotile textile and production workers: fibers longer than 18 mum. Inhal Toxicol, 12, 411-8.
38. Case BW, McDonald C. (2008). Chrysotile, tremolite, balangeroite and mesothelioma: similar situations? Occup Environ Med, 65, 815-9
39. Churg A. (1988). Chrysotile, tremolite and malignant mesothelioma. Chest, 93, 621-8.
40. Churg A, Wiggs B, Depaoli L, et al. (1984). Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis, 130, 1042-5.
41. Coin PG, Roggli VL, Brody AR. (1992). Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ Res, 58, 97-116.
42. Coleman RG. (1996). New Idria serpentinite: a land management dilemma. Environ Eng Geoscience, 2, 9-22.
43. Conway TL, Trent LK, Conway SW. (1989). Physical readiness and lifestyle habits among US navy personnel during 1986, 1987, and 1988. Technical Report No 89-23. San Diego, California: Naval Health Research Center.
44. Cressey BA, Whittaker EJW. (1993). Five-fold symmetry in chrysotile asbestos revealed by transmission electron microscopy. Mineral Mag, 57, 729-32.
45. Davis JM, Addison J, Bolton RE, et al. (1986). The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol, 67, 415-30.
46. Davis JM, Beckett ST, Bolton RE, et al. (1978). Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer, 37, 673-88.
47. Davis JM, Jones AD. (1988). Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol, 69, 717-37.
48. Dement JM, Brown DP. (1994). Lung cancer mortality among asbestos textile workers: a review and update. Ann Occup Hyg, 38, 525-32, 412.
49. Dement JM, Harris Jr RL, Symons MJ, et al. (1982). Estimates of doseresponse for respiratory cancer among chrysotile asbestos textile workers. Ann Occup Hyg, 26, 869-87.
50. Devesa SS, Grauman DJ, Blot WJ, et al. (1999). Atlas of cancer mortality in the United States 1950-1994 [NIH Publication No. 99-4564]. Bethesda (MD): National Institutes of Health, National Cancer Institute.
51. Dreessen WC, Dallavalle JM, Edwards TI, et al. (1938). A study of asbestosis in the asbestos textile industry [Public Health Bulletin No. 211]. Bethesda (MD): National Institute of Health, 91-125.
52. Elmes PC, Wade OL. (1965). Relationship between exposure to asbestos and pleural malignancy in Belfast. Ann N Y Acad Sci, 132, 549-57.
53. Esmen NA, Corn M. (1998). Airborne fiber concentrations during splitting open and boxing bags of asbestos. Toxicol Ind Health, 14, 843-56.
54. European Commission Joint Research Centre, Institute for Health and Consumer Protection, Unit: Toxicology and Chemical Substances, European Chemicals Bureau. (1999). Methods for the determination of the hazardous properties for human health of man made mineral fibers (MMMF).
55. Bernstein DM, Riego-Sintes JMR, eds, Vol. EUR 18748 EN, April 93. Available from: http://ecb.ei.jrc.it/DOCUMENTS/Testing-Methods/mmmfweb.pdf.
56. Evans BW. (2004). The serpentinite multisystem revisited: chrysotile is metastable. Int Geol Rev, 46, 479-506.
57. Finley BL, Pierce JS, Phelka AD, et al. (2012). Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol, 42, 119-46.
58. Gardner MJ, Winter PD, Pannett B, et al. (1986). Follow up study of workers manufacturing chrysotile asbestos cement products. Br J Ind Med, 43, 726-32.
59. Gazzano E, Riganti C, Tomatis M, et al. (2005). Potential toxicity of nonregulated asbestiform minerals: balangeroite from the western Alps. Part 3: depletion of antioxidant defenses. J Toxicol Environ Health Part A, 68, 41-9.
60. Gibbs GW. (1994). The assessment of exposure in terms of fibres. Ann Occup Hyg, 38, 477-87, 409-10.
61. Gibbs AR, Pooley F. (2008). Mineral fibers analysis and asbestos related diseases. In: Craighead JE, Gibbs AR, eds. Asbestos and its diseases. New York: Oxford University Press, 299-316.
62. Goodglick LA, Kane AB. (1990). Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res, 50, 5153-63.
63. Green FHY, Harley R, Vallyathan V, et al. (1997). Exposure and mineralogic correlates of pulmonary fibrosis in chrysotile asbestos workers. Occup Environ Med, 54, 549-59.
64. Groppo C, Tomatis M, Turci F, et al. (2005). Potential toxicity of nonregulated asbestiform minerals: balangeroite from the western Alps. Part 1: identification and characterization. J Toxicol Environ Health Part A, 68, 1-19.
65. Gross P, Cralley LJ, DeTreville RT. (1967). "Asbestos" bodies: their nonspecificity. Am Ind Hyg Assoc J, 28, 541-2.
66. Hain E, Dalquen P, Bohlig H, et al. (1974). [Retrospective study of 150 cases of mesothelioma in Hamburg area (author's transl)]. Int Arch Arbeitsmed, 33, 15-37.
67. Hammad Y, Simmons W, Abdel-Kader H, et al. (1988). Effect of chemical composition on pulmonary clearance of man-made mineral fibers. Ann Occup Hyg, 22, 769-79.
68. Hargreaves A, Taylor WH. (1946). An X-ray examination of decomposition products of chrysotile asbestos and serpentine. Mineral Mag, 27, 204-16.
69. Hein MJ, Stayner LT, Lehman E, et al. (2007). Follow-up study of chrysotile textile workers: cohort mortality and exposure-response. Occup Environ Med, 64, 616-25.
70. Hesterberg TW, Axten C, McConnell EE, et al. (1999). Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part I. Results of a subchronic study and dose selection for a chronic study. Inhal Toxicol, 11, 747-84.
71. Hesterberg TW, Hart GA, Chevalier J, et al. (1998). The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol, 153, 68-82.
72. Hesterberg TW, Miiller WC, McConnell EE, et al. (1993). Chronic inhalation toxicity of size-separated glass fibers in Fischer 344 rats. Fundam Appl Toxicol, 20, 464-76.
73. Hodgson JT, Darnton A. (2000). The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg, 44, 565-601.
74. Hughes JM, Weill H, Hammad YY. (1987). Mortality of workers employed in two asbestos cement manufacturing plants. Br J Ind Med, 44, 161-74.
75. Ilgren EB. (2004). Coalinga chrysotile a short fibre, amphibole free, chrysotile Part V-lack of amphibole asbestos contamination. Indoor Built Environ, 13, 375-82.
76. Ilgren EB, Breña MO, Larragoitia JC, et al. (2008a). A reconnaissance study of a potential emerging Mexican mesothelioma epidemic due to fibrous zeolite exposure. Indoor Built Environ, 17, 496-515.
77. Ilgren E, Chatfield E. (1997). Coalinga fibre-a short, amphibole-free chrysotile. Part 1: Evidence for lack of fibrogenic activity. Indoor Built Environ, 6, 264-76.
78. Ilgren E, Chatfield E. (1998). Coalinga fibre-a short, amphibole-free chrysotile. Part 2: Evidence for lack of tumorigenic activity. Indoor Built Environ, 7, 18-31.
79. Ilgren EB, Pooley FD, Larragoitia JC, et al. (2008b). First confirmed erionite related mesothelioma in North America. Indoor Built Environ, 17, 567-8.
80. Ilgren E, Ramirez R, Claros E, et al. (2012). Fiber width as a determinant of mesothelioma induction and threshold Bolivian crocidolite: epidemiological evidence from Bolivia mesothelioma demography and exposure pathways. Ann Respir Med. Available from: www.slmrespiratory. com.
81. ILO. (1984). Safety in the use of asbestos: an ILO code of practice. Geneva International Labour Office.
82. Jones RN, Diem JE, Hughes JM, et al. (1989). Progression of asbestos effects: a prospective longitudinal study of chest radiographs and lung function. Br J Ind Med, 46, 97-105.
83. Kanarek MS. (2011). Mesothelioma from chrysotile asbestos: update. Ann Epidemiol, 21, 688-97.
84. Karbownik J, Clark S. (1997, 2005, 2006, 2007, 2008, 2009, 2012). Determination of presence of amphibole asbestos fibres in four bulk samples of chrysotile [report to client, project no: 610]. Edinburgh, UK: IOM Consulting Limited.
85. Kashansky SV, Domnin SG, Kochelayev VA, et al. (2001). Retrospective view of airborne dust levels in workplace of a chrysotile mine in Ural, Russia. Ind Health, 39, 51-6.
86. Kliment CR, Clemens K, Oury TD. (2009). North American erioniteassociated mesothelioma with pleural plaques and pulmonary fibrosis: a case report. Int J Clin Exp Pathol, 2, 407-10.
87. Kobell F. (1834). Ueber den schillernden Asbest von Reichenstein in Schlesien. J Prakt Chemie, 2, 297-8.
88. Kurumatani N, Kumagai S. (2008). Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Respir Crit Care Med, 178, 624-9.
89. Larsen G. (1989). Experimental data on in vitro fibre solubility. IARC Sci Publ, 90, 134-9.
90. LeBouffant L, Daniel H, Henin JP, et al. (1987). Experimental study on long-term effects of inhaled MMMF on the lung of rats. Ann Occup Hyg, 31, 765-90.
91. Legifrance. (1994). Décret no 94-645 du 26 juillet 1994 modifiant le décret no 88-466 du 28 avril 1988 relatif aux produits contenant de l'amiante, JORF n-173 du 28 juillet 1994 page 10907. Available from: http://www.legifrance.gouv.fr.
92. Liddell FD, McDonald AD, McDonald JC. (1997). The 1891-1920 birth cohort of Quebec chrysotile miners and millers: development from 1904 and mortality to 1992. Ann Occup Hyg, 41, 13-36.
93. Liddell FDK, McDonald AD, McDonald JC. (1998). Dust exposure and lung cancer in Quebec chrysotile miners and millers. Ann Occup Hyg, 42, 7-20.
94. Lippmann M. (1990). Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect, 88, 311-7.
95. Mancuso TF. (1983). Mesothelioma among machinists in railroad and other industries. Am J Ind Med, 4, 501-13.
96. Mancuso TF. (1988). Relative risk of mesothelioma among railroad machinists exposed to chrysotile. Am J Ind Med, 13, 639-57. Erratum in: (1989). Am J Ind Med, 15, 125.
97. Mast RW, McConnell EE, Anderson R, et al. (1995). Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol, 7, 425-67.
98. McClellan RO, Miller FJ, Hesterberg TW, et al. (1992). Approaches to evaluating the toxicity and carcinogenicity of man-made fibers: summary of a workshop held November 11-13, 1991, Durham, North Carolina. Regul Toxicol Pharmacol, 16, 321-64.
99. McConnell EE, Axten C, Hesterberg TW, et al. (1999). Studies on the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal Toxicol, 11, 785-835.
100. McDonald AD, Case BW, Churg A, et al. (1997). Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg, 41, 707-19.
101. McDonald AD, Fry JS, Woolley AJ, et al. (1983). Dust exposure and mortality in an American factory using chrysotile, amosite, and crocidolite in mainly textile manufacture. Br J Ind Med, 40, 368-74.
102. McDonald AD, Fry JS, Woolley AJ, et al. (1984). Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Ind Med, 41, 151-7.
103. McDonald AD, Harper A, McDonald JC, et al. (1970). Epidemiology of primary malignant mesothelial tumors in Canada. Cancer, 26, 914-19.
104. McDonald JC, Liddell FD. (1979). Mortality in Canadian miners and millers exposed to chrysotile. Ann NY Acad Sci, 330, 1-9.
105. McDonald JC, McDonald AD. (1995). Chrysotile, tremolite and mesothelioma. Science, 267, 775-6.
106. McDonald JC, McDonald AD. (1996). The epidemiology of mesothelioma in historical context. Eur Respir J, 9, 1932-42.
107. McEwen J, Finlayson A, Mair A, et al. (1970). Mesothelioma in Scotland. Br Med J, 4, 575-8.
108. Morgan A. (1995). Deposition of inhaled asbestos and manmade mineral fibres in the respiratory tract. Ann Occup Hyg, 39, 747-58.
109. Morris GF, Notwick AR, et al. (2004). Development of lung tumors in mutant p53-expressing mice after inhalation exposure to asbestos. Chest, 125, 85S-6S.
110. Morrow PE. (1988). Possible mechanisms to explain dust overloading of the lung. Fundam Appl Toxicol, 10, 369-84.
111. Morrow PE. (1992). Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol, 113, 1-12.
112. Muhle H, Bellman B, Heinrich U. (1988). Overloading of lung clearance during chronic exposure of experimental animals to particles. Ann Occup Hyg, 32, 141-7.
113. Muhle H, Pott F, Bellmann B, et al. (1987). Inhalation and injection experiments in rats to test the carcinogenicity of MMMF. Ann Occup Hyg, 31, 755-64.
114. Musti M, Pollice A, Cavone D, et al. (2009). The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy). Int Arch Occup Environ Health, 82, 489-97.
115. Newhouse ML, Sullivan KR. (1989). A mortality study of workers manufacturing friction materials: 1941-86. Br J Ind Med, 46, 176-9.
116. Newhouse ML, Thompson H. (1965). Mesothelioma of pleura and peritoneum following exposure to asbestos in the London area. Br J Ind Med, 22, 261-9.
117. NIOSH. (2011). Asbestos fibers and other elongate mineral particles: state of the science and roadmap for research [revised April 2011, publication number 2011-159, current intelligence bulletin 62]. Washington (DC): Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health.
118. Noll W, Kircher H. (1951). Ü ber die Morphologie von Asbesten und ihren Zusammenhang mit der Kristallstruktur. Neues Jb. Mineral., Mh. 1951, 219-40.
119. Oberdörster G. (1995). Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol, 21, 123-35.
120. Ohlson CG, Hogstedt C. (1985). Lung cancer among asbestos cement workers. A Swedish cohort study and a review. Br J Ind Med, 42, 397-402.
121. Osmond-McLeod MJ, Poland CA, Murphy F, et al. (2011). Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part Fibre Toxicol, 8, 15.
122. Oze C, Solt K. (2010). Biodurability of chrysotile and tremolite asbestos in simulated lung and gastric fluids. Am Mineral, 95, 825-31.
123. Pan XL, Day HW, Wang W, et al. (2005). Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med, 172, 1019-25.
124. Pauling L. (1930). The structure of the chlorites. Proc Nat Acad Sci USA, 16, 578-82.
125. Paustenbach DJ, Finley BL, Lu ET, et al. (2004). Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads (1900 to present): A 'state-of-the-art review'. J Toxicol Environ Health, Part B, 7, 33-110.
126. Perry RH, Chilton CH, eds. (1973). Chemical engineers' handbook. 5th ed. New York (NY): McGraw-Hill. TIC: 242591.
127. Pierce JS, McKinley MA, Paustenbach DJ, et al. (2008). An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma. Crit Rev Toxicol, 38, 191-214.
128. Pinkerton KE, Brody AR, McLaurin DA, et al. (1983). Characterization of three types of chrysotile asbestos after aerosolization. Environ Res, 31, 32-53.
129. Piolatto G, Negri E, La Vecchia C, et al. (1990). An update of cancer mortality among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med, 47, 810-4.
130. Pohanish RP, ed. 2008 Sittig's handbook of toxic and hazardous chemicals and carcinogens. 5th ed. Norwich (NY): William Andrews 272.
131. Poland CA, Duffin R, Kinloch I, et al. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol, 3, 423-8.
132. Pooley F. (2003). Personal communication of a report prepared under contract to KCAC of the examination of chrysotile asbestos samples from the asbestos mine and processing plant of KCAC, Inc., 1991.
133. Cited in Bernstein DM, Chevalier J, Smith P. (2005). Comparison of calidria chrysotile asbestos to pure tremolite: Final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol, 17, 427-49.
134. Pooley FD, Mitha R. (1986). Determination and interpretation of the levels of chrysotile asbestos in lung tisue. In: Wagner JC, ed. Biological effects of chrysotile. Accomplishments in Oncology Vol. 1. No. 2. Philadelphia: Lippincott, 12-18.
135. Roggli VL, Pratt PC, Brody AR. (1992). Analysis of tissue mineral fiber content. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of asbestos-associated diseases. Chap. 11. Boston (MA): Little, Brown, 299-345.
136. Roggli VL, Sharma A, Butnor KJ, et al. (2002b). Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol, 26, 55-65.
137. Roggli VL, Vollmer RT, Butnor KJ, et al. (2002a). Tremolite and mesothelioma. Ann Occup Hyg, 46, 447-53.
138. Rubino GF, Scansetti G, Donna A, et al. (1972). Epidemiology of pleural mesothelioma in North-western Italy (Piedmont). Br J Ind Med, 29, 436-42.
139. Schneider F, Sporn TA, Roggli VL. (2010). Asbestos fiber content of lungs with diffuse interstitial fibrosis: An analytical scanning electron microscopic analysis of 249 cases. Arch Pathol Lab Med, 134, 457-61.
140. Sebastien P, McDonald JC, McDonald AD, et al. (1989). Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis. Br J Ind Med, 46, 180-7.
141. Selikoff IJ, Churg J, Hammond EC. (1984). Landmark article April 6, 1964: Asbestos exposure and neoplasia. By Irving J. Selikoff, Jacob Churg, and E. Cuyler Hammond. JAMA, 252, 91-5.
142. Seshan K. (1983). How are the physical and chemical properties of chrysotile asbestos altered by a 10-year residence in water and up to 5 days in simulated stomach acid? Environ Health Perspect, 53, 143-8
143. Sichletidis L, Chloros D, Spyratos D, et al. (2009). Mortality from occupational exposure to relatively pure chrysotile: a 39-year study. Respiration, 78, 63-8.
144. Silvestri S, Magnani C, Calisti R, et al. (2001). The experience of the Balangero chrysotile asbestos mine in Italy: health effects among workers mining and milling asbestos and the health experienceof persons living nearby. In: Nolan RP, Langer AM, Ross M, Wicks FJ, Martin RF, eds. The health effects of chrysotile asbestos: contribution of science to risk-management decisions. Ottawa, Canada: Canadian Mineralogist, Spec. Publ. 5, 177-86.
145. Skinner HCW, Ross M, Frondel C. (1988). Asbestos and other fibrous materials-mineralogy, crystal chemistry, and health effects. New York (NY): Oxford University Press, 204.
146. Smith AH, Wright CC. (1996). Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med, 30, 252-66.
147. Speil S, Leineweber JP. (1969). Asbestos minerals in modern technology. Environ Res, 2, 166-208.
148. Stanton MF. (1973). Some etioligical considerations of fibre carcinogenesis. In: Bogovski P, Gilson JC, Timbrell V, Wagner JC, eds. Biological effects of asbestos. Lyon: WHO IARC, 289-94.
149. Stanton MF, Layard M, Tegeris A, et al. (1981). Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst, 67, 965-75.
150. Stanton MF, Wrench C. (1972). Mechanisms of mesothelioma induction with asbestos & fiberous glass. J Natl Cancer Inst, 48, 797-821.
151. Stayner L, Kuempel E, Gilbert S, et al. (2008). An epidemiological study of the role of chrysotile asbestos fiber dimensions in determining respiratory disease risk in exposed workers. Occup Environ Med, 65, 613-9.
152. Suquet H. (1989). Effects of dry grinding and leaching on the crystal structure of chrysotile. Clays Clay Miner, 37, 439-45.
153. Thomas HF, Benjamin IT, Elwood PC, et al. (1982). Further follow-up study of workers from an asbestos cement factory. Br J Ind Med, 39, 273-6.
154. Timbrell V, Hyett AW, Skidmore JW. (1968). A simple dispenser for generating dust clouds from standard reference samples of asbestos. Ann Occup Hyg, 11, 273-81.
155. Timbrell V, Rendall REG. (1972). Preparation of the UICC standard reference samples of asbestos. Powder Technol, 5, 279-87.
156. Titulaer MK, van Miltenburg JC, Jansen JBH, et al. (1993). Characterization of tubular chrysotile by thermoporometry, nitrogen sorption, drifts, and TEM. Clays Clay Miner, 41, 496-513.
157. Tossavainen A, Kotilainen M, Takahashi K, et al. (2001). Amphibole fibres in Chinese chrysotile asbestos. Ann Occup Hyg, 45, 145-52.
158. Tossavainen A, Kovalevsky E, Vanhala E, et al. (2000). Pulmonary mineral fibers after occupational and environmental exposure to asbestos in the Russian chrysotile industry. Am J Ind Med, 37, 327-33.
159. Tossavainen A, Riala R, Kamppi R, et al. (1996). Dust measurements in the chrysotile mining and milling operations of Uralasbest Company, Asbest, Russia [summary report]. Helsinki: Institute of Occupational Health, 220.
160. Turci F, Tomatis M, Gazzano E, et al. (2005). Potential toxicity of nonregulated asbestiform minerals: balangeroite from the western Alps. Part 2: oxidant activity of the fibers. J Toxicol Environ Health Part A, 68, 21-39.
161. US DHHS. (1989). Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General, 1989 [DHHS Publication No (CDC) 89-8411]. Rockville (MD): Public Health Service, Centers for Disease Control, Office on Smoking and Health.
162. US EPA. (2001). US EPA health effects test guidelines OPPTS 870.8355 guideline for combined chronic toxicity/carcinogenicity testing of respirable fibrous particles [EPA 712-C-01-352, July]. Washington (DC): US Environmental Protection Agency.
163. Van Orden DR, Lee RL, Sanchez MS, et al. (2012). The size distribution of airborne Bolivian crocidolite fibers [case report]. The Annals of Respiratory Medicine. Monroeville (PA): RJ Lee Group, Inc. Available from: www.slm-respiratory.com [last accessed 26 Jul 2012].
164. Veblen DR, Wylie AG. (1993). Mineralogy of amphiboles and 1:1 layer silicates. In: Guthrie Jr GD, Mossman BT, eds. Health effects of mineral dusts. Washington (DC): Mineralogical Society of America, Reviews in Mineralogy, Vol. 28, 61-137.
165. Virta RL. (2002). Asbestos: geology, mineralogy, mining, and uses. Prepared in cooperation with Kirk-Othmer encyclopedia of chemical technology. USGS Open file 02-149. Online Edition. New York (NY): Wiley-Interscience, a division of John Wiley & Sons, Inc.
166. Virta RL. (2005). Mineral commodity profiles-asbestos [US Geological Survey circular 1255-KK]. Reston (VA): US Geological Survey.
167. Virta RL. (2006). Worldwide asbestos supply and consumption trends from 1900 through 2003 [circular 1298]. Reston (VA): US Geological Survey.
168. Virta RL. (2011). 2010 minerals yearbook-asbestos. US Geological Survey Minerals Yearbook-2010. Reston (VA): US Geological Survey.
169. von Kobell F. (1834). Ueber den schillernden Asbest von Reichenstein in Schlesian: Jour. Prakt. Chemie, 2, 297-8.
170. Vorwald AJ, Durkan TM, Pratt PC. (1951). Experimental studies of asbestosis. AMA Arch Ind Hyg Occup Med, 3, 1-43.
171. Wagner JC, Berry G, Skidmore JW, et al. (1974). The effects of the inhalation of asbestos in rats. Br J Cancer, 29, 252-69.
172. Wagner JC, Berry G, Skidmore JW, et al. (1980). The comparative effects of three chrysotiles by injection and inhalation in rats. In: Wagner JC, ed. Biological Effects of Mineral Fibers. IARC Publication 30. Lyon: International Agency Research on Cancer, 363-73.
173. Wagner JC, Sleggs CA, Marchand P. (1960). Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med, 17, 260-71.
174. Walton WH. (1982). The nature, hazards, and assessment of occupational exposure to airborne asbestos dust: a review. Ann Occup Hyg, 25, 117-247.
175. Wang X, Yano E, Qiu H, et al. (2012). A 37-year observation of mortality in Chinese chrysotile asbestos workers. Thorax, 67, 106-10.
176. Warren BE, Bragg WL. (1930). The structure of chrysotile, H4Mg3Si2O9. Z Krystallographie, 76, 201-10.
177. Weill H, Hughes J, Waggenspack C. (1979). Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis, 120, 345-54.
178. White N, Nelson G, Murray J. (2008). South African experience with asbestos related environmental mesothelioma: is asbestos fiber type important? Regul Toxicol Pharmacol, 52, S92-6
179. Whittaker EJW. (1957). The structure of chrysotile. V. Diffuse reflexions and fibre texture. Acta Cryst, 10, 149-56.
180. Whittaker EJW. (1957). The Structure of Chrysotile. V. Diffuse Reflexions and Fibre Texture. Acta Cryst, 10, 149-56.
181. Whittaker EJW. (1960). The crystal chemistry of the amphiboles. Acta Cryst, 13, 291-98.
182. Whittaker EJW. (1963). in Research report: Chrysotile Fibers-Filled or Hollow Tubes? Mathematical interpretation may resolve conflicting evidence. Chem Eng News, 41, 34-35, September 30, 1963.
183. WHO. (1985). Reference methods for measuring airborne man-made mineral fibers (MMMF): WHO/EURO MMMF reference scheme. Copenhagen: WHO.
184. WHO. (1988). Environmental health criteria 77: man-made mineral fibres. Vol. 77. Geneva: WHO.
185. Wicks FJ, O'Hanley DS. (1988). Serpentine minerals: structures and petrology. In: Bailey S, ed. Hydrous phyllosilicates (exclusive of micas). Washington, DC: Mineralogical Society of America, Reviews in Mineralogy, Vol.
186. Williams-Jones AE, Normand C, Clark JR, et al. (2001). Controls of amphibole formation in chrysotile deposits: evidence from the Jeffrey Mine, Asbestos, Quebec. In: Nolan RP, Langer AM, Ross M, Wicks FJ, Martin RF, eds. The health effects of chrysotile asbestos: contribution of science to risk-management decisions. Ottawa, Canada: Canadian Mineralogist, Spec. Publ. 5, 89-104.
187. Work LT. (1962). Size reduction gets a new stature. Ind Eng Chem, 54, 52-4.
188. Wypych F, Adad LB, Mattoso N, et al. (2005). Synthesis and characterization of disordered layered silica obtained by selective leaching of octahedral sheets from chrysotile. J Colloid Interface Sci, 283, 107-12.
189. Yano E, Wang ZM, Wang XR, et al. (2001). Cancer mortality among workers exposed to amphibole-free chrysotile asbestos. Am J Epidemiol, 154, 538-43.
190. Yano E, Wang ZM, Wang XR, et al. (2009). Mesothelioma in a worker who spun chrysotile asbestos at home during childhood. Am J Ind Med, 52, 282-7.
191. Yarborough CM. (2006). Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Crit Rev Toxicol, 36, 165-87.
192. Zamataro RSI, Franzini MJ. (2012). Verificar qualitativamente a tipologia das amostras de amianto extra?́das na SAMA, por análise difratométrica de raios X [Relatório N-021E-12]. São Paulo-SP, Brazil: Projecontrol Cons. Empresarial e Serviços Ltda.
193. Zielhuis RL, Versteeg JP, Planteijdt HT. (1975). Pleura mesothelioma and exposure to asbestos. A retrospective case-control study in the Netherlands. Int Arch Occup Environ Health, 36, 1-18.